New hope for Tough-to-Treat neuroendocrine tumors: Real-Life drug tracking

NCT ID NCT07314164

Recruiting now Disease control Sponsor: Ipsen Source: ClinicalTrials.gov ↗

Summary

This study is observing how well the cancer drug cabozantinib works and how safe it is for adults with advanced neuroendocrine tumors (NETs) who have already tried at least one other treatment. It will follow about 150 patients in Germany and Austria who are already receiving this drug as part of their standard care. Doctors will collect information from regular check-ups and scans to see if the cancer stops growing, how long patients stay on the treatment, and how it affects their daily life and side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asklepios Kliniken Hamburg
NOT_YET_RECRUITING

Hamburg, Germany
Evangelische Lungenklinik Berlin
NOT_YET_RECRUITING

Berlin, Germany
Gemeinschaftspraxis Haematologie - Onkologie
NOT_YET_RECRUITING

Dresden, Germany
Kepler Universitaetsklinikum GmbH Linz
NOT_YET_RECRUITING

Linz, Germany
Krankenhaus Nordwest
NOT_YET_RECRUITING

Frankfurt, Germany
Krankenhaus St. Joseph-Stift Bremen GmbH
RECRUITING

Bremen, Germany
MVZ Leipzig Mitte, MVZ Delitzsch
NOT_YET_RECRUITING

Leipzig, Germany
MVZ Muelheim an der Ruhr GmbH
NOT_YET_RECRUITING

Mülheim, Germany
MVZ am Klinikum Aschaffenburg
NOT_YET_RECRUITING

Aschaffenburg, Germany
MVZ fuer Haematologie und Onkologie Koeln am Sachsenring
NOT_YET_RECRUITING

Cologne, Germany
Medizinische Studiengesellschaft Nord-West
RECRUITING

Westerstede, Germany
Medizinische Universitaet Graz
NOT_YET_RECRUITING

Graz, Austria
Studienzentrum UnterEms
NOT_YET_RECRUITING

Leer, Germany
Universitaetsklinikum Essen
NOT_YET_RECRUITING

Essen, Germany
Universitaetsklinikum Giessen-Marburg
NOT_YET_RECRUITING

Giesen, Germany
Universitaetsklinikum Wuerzburg
RECRUITING

Würzburg, Germany
Universitaetsmedizin Goettingen
NOT_YET_RECRUITING

Goettigen, Germany
Universitätsklinikum Tuebingen
NOT_YET_RECRUITING

Tübingen, Germany

Conditions

Explore the condition pages connected to this study.

NEUROENDOCRINE TUMORS